Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Shows Brain Anatomy Differences Between Autistic and Typically Developing Individuals to Be Mostly Indistinguishable

By HospiMedica International staff writers
Posted on 24 Nov 2014
In the largest magnetic resonance imaging (MRI) study of patients with autism to date, Israeli and American researchers have shown that the brain anatomy in MRI scans of autistic individuals older than age six is mostly indistinguishable from that of typically developing individuals, and therefore, of little clinical or scientific value. More...


The researchers from Ben-Gurion University of the Negev (BGU; Be’er Sheva, Israel) and Carnegie Mellon University (Pittsburgh, PA, USA) published their findings online October 14, 2014, in the Oxford journal Cerebral Cortex. “Our findings offer definitive answers regarding several scientific controversies about brain anatomy, which have occupied autism research for the past 10 to 15 years,” said Dr. Ilan Dinstein of BGU’s departments of psychology and brain and cognitive sciences. “Previous hypotheses suggesting that autism is associated with larger intracranial gray matter, white matter, and amygdala volumes, or smaller cerebellar, corpus callosum and hippocampus volumes were mostly refuted by this new study.”

The researchers used data from the Autism Brain Imaging Data Exchange (ABIDE), which provides an unprecedented prospect to conduct large-scale comparisons of anatomic MRI scans across autism and control groups and resolve many outstanding questions. This recently released database is a worldwide collection of MRI scans from over 1,000 individuals (half with autism and half controls) ages 6 to 35 years old.

“In the study we performed very detailed anatomical examinations of the scans, which included dividing each brain into over 180 regions of interest and assessing multiple anatomical measures such as the volume, surface area and thickness of each region,” Dr. Dinstein stated.

The researchers then examined how the autism and control groups differed with respect to each region and also with respect to groups of regions using more complex analyses. “The most striking finding here was that anatomical differences within both the control group and the autistic group was immense and greatly overshadowed minute differences between the two groups,” Dr. Dinstein noted. “For example, individuals in the control group differ by 80% to 90% in their brain volumes, while differences in brain volume across autism and control groups differed by 2% to 3% percent at most. This led us to the conclusion that anatomical measures of brain volume or surface areas do not offer much information regarding the underlying mechanism or pathology of autistic spectrum disorder [ASD],” he stated. “These sobering results suggest that autism is not a disorder that is associated with specific anatomical pathology and as a result, anatomical measures alone are likely to be of low scientific and clinical significance for identifying children, adolescents and adults with ASD, or for elucidating their neuropathology.”

Dr. Dinstein believes that more complicated explanations involving combinations of measures in more homogeneous subgroups are in all probability to be the answer. “Expecting to find a single answer for the entire ASD population is naive. We need to move on to thinking about how to split up this very heterogeneous group of disorders into more meaningful biologically-relevant subgroups,” he stated.

This conclusion stands in great contrast to numerous reports of significant anatomical differences described by smaller studies, which have typically included comparisons of 40 to 50 individuals. “The problem with small samples, large within-group heterogeneity, and a scientific bias to report only positive findings, is that small samples are likely to yield significant differences across autism and control groups in a few of the 180 brain regions,” Dr. Dinstein explained.

“In such a situation one would expect that each study would find significant differences in different brain areas and that findings will be very inconsistent across studies," he says. "This is exactly what you see when you examine the autism anatomy literature from the last decade or so. Our study simply explains why this has been happening and puts an end to several ensuing debates.”

Related Links:

Ben-Gurion University of the Negev
Center of Cognitive Brain Imaging, Carnegie Mellon University
Carnegie Mellon University



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Medical Monitor
VITALMAX 4100SL
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.